We are live on ! Find out more
LICN icon

Lichen China

4 hedge funds and large institutions have $242K invested in Lichen China in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

100% more funds holding

Funds holding: 2 → 4 (+2)

67% more capital inflows, than outflows

Capital inflows: $231K | Capital outflows: $138K

0.44% more ownership

Funds ownership: 1.03% → 1.47% (+0.44%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Marex Group
Marex Group
+$96.7K
2
Jane Street
Jane Street
New York
+$93.7K
3
Two Sigma Investments
Two Sigma Investments
New York
+$40.2K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$107K
2
Virtu Financial
Virtu Financial
New York
-$31K

LICN Hedge Fund Activity: Q3 2026 in Review

4 of the 8,221 institutional investors tracked by Wall St. Rank reported a position in Lichen China (LICN) for Q3 2026, worth a combined $242K — up 47% from $165K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new LICN positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Marex Group, opening a new position worth an estimated $96.7K. The largest seller was UBS Group, cutting an estimated $107K.

  • 4 institutional investors held Lichen China (LICN) as of Q3 2026, up from 2 in Q2 2026.
  • Funds reported $242K of Lichen China stock for Q3 2026, up 47% quarter-over-quarter.
  • 3 funds opened new Lichen China positions in Q3 2026 and 1 closed out, a net change of +2 holders.
  • The largest Lichen China buyer in Q3 2026 was Marex Group, an estimated $96.7K added.
  • The largest Lichen China seller in Q3 2026 was UBS Group, an estimated $107K sold.

Based on aggregated 13F filings for Q3 2026.